Yakov Elgudin, MD, PhD
Biography
- Director, Lung Transplantation, UH Cleveland Medical Center
- Assistant Professor, CWRU School of Medicine
- Associate Professor, CWRU School of Medicine
Expertise
- Adult Cardiothoracic Surgery
- Aortic Surgery
- Cardiac Surgery
- Coronary Artery Bypass Graft Surgery (CABG) - Off Pump
- Coronary Revascularization
- Heart Failure
- Heart Transplantation
- Mechanical Circulatory Support
- Minimally Invasive Valve Replacement
- Percutaneous Thoracic Aortic Repair
- Percutaneous Valve Repair
- Robotic Surgery
- Structural Heart Disease
- Transcatheter Aortic Heart Valve Replacement
- Transplant Surgery
- Valve Repair
Languages Spoken
English, Russian
Office Locations
Certifications & Memberships
- Thoracic and Cardiac Surgery - American Board of Thoracic Surgery
- Surgery - American Board of Surgery
Education
Fellowship | Pediatric Cardiothoracic Surgery
Pediatric Cardiothoracic Surgery - UH Case Medical Center (2004 - 2005)
Fellowship | Cardiothoracic Surgery
Cardiothoracic Surgery - Ucla David Geffen School Of Medicine/Ucla Medical Center (2003 - 2004)
Fellowship | Cardiothoracic Surgery
Cardiothoracic Surgery - University Hospitals Of Cleveland (2002 - 2003)
Residency | General Surgery
General Surgery - Exempla St Joseph Hospital (1998 - 2002)
Internship | General Surgery
General Surgery - Exempla St Joseph Hospital (1997 - 1998)
Research Fellowship | Cardiothoracic Surgery
Cardiothoracic Surgery - Mount Sinai Morningside (1996 - 1997)
Other Education
Institute Of Transplantology And Artificial Organs (1995)
Other Education
Institute Of Transplantology And Artificial Organs (1991)
Medical Education
Kemerovo State Medical Academy (1989)
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Yakov Elgudin did not disclose any Outside Relationships with Industry.